Financial Statements · From SEC 10-K & 10-Q XBRL Filings
Lam Research Corporation Revenue & Financial Statements
Lam Research Corporation reported revenue of $18.4B for the fiscal year ended June 29, 2025, up 23.7% year over year, with net income of $5.4B and diluted EPS of $4.15.
- Company
- Lam Research Corporation LRCX · NASDAQ
- Latest fiscal year
- FY ended Jun 29, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 14.6B | 17.2B | 17.4B | 14.9B | 18.4B |
| Cost of revenue | 7.8B | 9.4B | 9.7B | 7.9B | 9.5B |
| Gross profit | 6.8B | 7.9B | 7.8B | 7.1B | 9.0B |
| Operating income | 4.5B | 5.4B | 5.2B | 4.3B | 5.9B |
| Pretax income | 120.2M | 87.9M | 151.8M | 282.7M | 219.4M |
| Net income | 3.9B | 4.6B | 4.5B | 3.8B | 5.4B |
| Diluted EPS | 26.90 | 32.75 | 33.21 | 29.00 | 4.15 |
| EBITDA | 4.7B | 5.6B | 5.5B | 4.6B | 6.2B |
Quarterly
| USD | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.9B | 4.2B | 4.4B | 4.7B | 5.2B | 5.3B | 5.3B | 5.8B |
| Cost of revenue | 2.0B | 2.2B | 2.3B | 2.4B | 2.6B | — | — | — |
| Gross profit | 1.8B | 2.0B | 2.1B | 2.3B | 2.6B | 2.7B | 2.7B | 2.9B |
| Operating income | 1.1B | 1.3B | 1.3B | 1.6B | 1.7B | 1.8B | 1.8B | 2.0B |
| Pretax income | 1.2B | 1.3B | 1.3B | 1.5B | 1.8B | 1.9B | 1.8B | 2.0B |
| Net income | 1.0B | 1.1B | 1.2B | 1.3B | 1.7B | 1.6B | 1.6B | 1.8B |
| Diluted EPS | 7.78 | 0.86 | 0.92 | 1.03 | 1.34 | 1.24 | 1.26 | 1.45 |
| EBITDA | 1.2B | 1.4B | — | 1.7B | 1.8B | 1.9B | — | 2.2B |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 15.9B | 17.2B | 18.8B | 18.7B | 21.3B |
| Current assets | 11.7B | 12.3B | 13.2B | 12.9B | 14.5B |
| Cash & equivalents | 4.4B | 3.5B | 5.3B | 5.8B | 6.4B |
| Total liabilities | 9.9B | 10.9B | 10.6B | 10.2B | 11.5B |
| Current liabilities | 3.5B | 4.6B | 4.2B | 4.3B | 6.6B |
| Long-term debt | 5.0B | — | 5.0B | 4.5B | 3.7B |
| Total debt | 5.0B | — | 5.0B | 5.0B | 4.5B |
| Stockholders’ equity | 6.0B | 6.3B | 8.2B | 8.5B | 9.9B |
| Net debt | 542.7M | — | (371.7M) | (880.5M) | (1.9B) |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 3.6B | 3.1B | 5.2B | 4.7B | 6.2B |
| Investing cash flow | 73.3M | 612.3M | (534.6M) | (370.6M) | (708.1M) |
| Financing cash flow | (4.2B) | (4.6B) | (2.8B) | (4.0B) | (4.9B) |
| Capital expenditure | — | — | — | — | — |
| Free cash flow | — | — | — | — | — |
| Dividends paid | 727.0M | 815.3M | 907.9M | 1.0B | 1.1B |
| Stock-based compensation | 220.2M | 259.1M | 286.6M | 293.1M | 343.4M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every LRCX filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.